Reactive Oxygen Species in Cardiometabolic Syndrome, Neuronal Diseases and Cancer
From Bench to its Potential Therapeutics
- Publisher's listprice EUR 163.99
-
68 014 Ft (64 776 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 13 603 Ft off)
- Discounted price 54 412 Ft (51 821 Ft + 5% VAT)
- Discount is valid until: 31 December 2025
Subcribe now and take benefit of a favourable price.
Subscribe
68 014 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 27 August 2025
- ISBN 9780443273339
- Binding Paperback
- No. of pages382 pages
- Size 235x191 mm
- Weight 800 g
- Language English 682
Categories
Long description:
Reactive Oxygen Species in Cardiometabolic Syndrome, Neuronal Diseases and Cancer: From Bench to its Potential Therapeutics systematically summarizes findings concerning the biochemical properties of various reactive oxygen species (ROS). The book opens with foundational coverage of ROS, ROS signaling, as well as the role of ROS in controlling gene expression. Subsequent chapters cover molecular mechanisms of ROS, regulation of gene expression, and antioxidant supplementation with cardiometabolic syndrome, various neuronal diseases, and cancer. It concludes with recent findings on therapeutic modulations of intracellular levels of ROS, which may significantly impact the development of novel agents for treating the conditions covered.
This is a must-have reference for scientists and medical professionals seeking to enhance their knowledge of ROS research and the impact on treatments for cardiometabolic syndrome, neuronal diseases, and cancer.
Table of Contents:
Section 1. Introduction to ROS
1. ROS in general
2. ROS signaling
3. ROS and regulation of gene expression
Section 2. ROS in cardiometabolic syndrome
4. Molecular Mechanisms of ROS in cardiometabolic syndrome
5. Molecular Mechanisms of ROS and Regulation of Gene expression in cardiometabolic syndrome
6. Antioxidant supplementation and Cardiometabolic syndrome
Section 3. ROS and neuronal diseases
7. Molecular Mechanisms of ROS in neurodegenerative diseases (Alzheimer, Parkinson, etc.)
8. ROS and psychiatric diseases (schizophrenia, etc.)
9. Antioxidant supplementation and neuronal diseases
Section 4. ROS and cancer
10. ROS and early stage of cancer (cancer development)
11. ROS and late-stage cancer (cancer metastasis)
12. Antioxidant supplementation and cancer
Section 5. Summary and concluding remarks
